GNOM

Global X Genomics & Biotechnology ETF
NasdaqGMUSDETF / FUND DELAYED
Last price
67.60
▼ 4.70 (6.50%)
MARKET · —

Price

1D — H — L — Range — Vol —
Drag pan · Pinch zoom · Hold crosshair · pick a tool then drag to draw
Open
—
Prev close
72.30
Day high
74.19
Day low
67.49
Volume
85.70K
Market cap
—
P/E (TTM)
—
52W range
40.17 – 74.19

Trailing performance

Price return · vs SPY
Returnvs SPY
1W
-3.91% -5.9%
1M
+5.20% +4.0%
3M
+17.89% +13.4%
6M
+53.62% +35.4%
YTD
+48.72% +34.5%
1Y
+65.09% +48.7%
3Y
+66.18% -16.1%
5Y
— —

Price return only. Dividends are not reinvested, so total return on a dividend payer will be higher than shown.

Top holdings

10 shown · by weight
SymbolNameWeight
MRNA Moderna Inc 9.45%
TWST Twist Bioscience Corp 8.10%
TXG 10x Genomics Inc Ordinary Shares - Class A 7.28%
ILMN Illumina Inc 5.72%
GH Guardant Health Inc 5.43%
NTRA Natera Inc 5.43%
1548.HK Genscript Biotech Corp Class H 4.63%
TECH Bio-Techne Corp 3.38%
VRTX Vertex Pharmaceuticals Inc 3.26%
BMRN BioMarin Pharmaceutical Inc 3.02%

Sector exposure

Fund weightings
Healthcare
99.74%
Technology
0.26%

Fund profile

As reported
Fund familyGlobal X Funds
CategoryHealth
Legal typeExchange Traded Fund
Expense ratio0.50%
Turnover34.0%
Total net assets$15.65M

Unusual options activity

Account required
Nothing crossed the thresholds in the expiries we scanned.
That is the normal state — most contracts trade well inside their existing open interest.
Free account required

Contracts trading at or above their open interest, ranked by notional and where the print landed.

Free account

5 more panels on GNOM open with an account.

Options chains and analytics, valuation ratios, insider filings, analyst targets and ownership. No card, no trial, nothing to cancel.

Fundamentals

TTM · reported
Market cap—
Enterprise value—
Revenue (TTM)—
Gross profit—
EBITDA—
Net income—
EPS (TTM)—
Free cash flow—
Total cash—
Total debt—
Book value / share—
Shares outstanding—
Float—
Short % of float—
Dividend yield—
Beta (5Y)—

Valuation & profitability ratios

Account required
Trailing P/E—
Forward P/E—
PEG ratio—
Price / sales—
Price / book—
EV / revenue—
EV / EBITDA—
Gross margin—
Operating margin—
Profit margin—
Return on equity—
Return on assets—
Debt / equity—
Current ratio—
Free account required

Fourteen ratios including P/E, PEG, EV/EBITDA, margins and return on equity.

Options analytics

Account required
Put / call volume
1.00
Call-heavy session
Put / call open interest
—
Positioning, not flow
Max pain
60.00
-11.2% from spot
ATM implied vol
1.6%
Nearest strike to spot
Skew (10% OTM)
+4.7%
Puts bid over calls
Call volume
2
Contracts, this expiry
Put volume
2
Contracts, this expiry
Heaviest call OI
60.00
0 contracts
Heaviest put OI
64.00
0 contracts

Max pain is the strike at which the largest dollar value of open contracts expires worthless. It describes current positioning; it is not a forecast and it moves as open interest changes.

Free account required

Put/call ratios, max pain, implied volatility skew and where open interest is concentrated.

Analyst targets & ownership

Account required
Mean target—
High target—
Low target—
Implied upside—
Analyst count—
Consensus—
Strong buy / Buy— / —
Hold—
Sell / Strong sell— / —
Held by insiders—
Held by institutions—
Institutions holding—
Free account required

Price targets, consensus spread, insider and institutional ownership.

Moving averages & technicals

Computed from 2Y daily closes
SMA 10
69.77
-3.10% from price
SMA 20
67.28
+0.48% from price
SMA 50
63.51
+6.43% from price
SMA 100
57.69
+17.18% from price
SMA 200
51.92
+30.21% from price
EMA 12
68.97
-1.98% from price
EMA 26
67.08
+0.78% from price
EMA 50
64.07
+5.52% from price
RSI (14)
51.9
Neutral
MACD (12,26,9)
1.89
Hist -0.10
ATR (14)
2.21
3.27% of price
Realised vol 30D
37.3%
Annualised
Bollinger upper
73.59
20, 2σ
Bollinger lower
60.96
20, 2σ
50 / 200 cross
Golden
63.51 vs 51.92
Trend bias
Above 200
+30.21%

Options chain

Account required
Expiry
Spot 67.60
Calls
StrikeLastBidAskVolOIIV
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
Puts
StrikeLastBidAskVolOIIV
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
Free account required

Every listed expiry, both sides of the book, with volume, open interest and implied volatility.

Risk profile

Daily returns · 1Y window
Beta vs SPY
1.18
More volatile than market
Correlation to SPY
0.47
Loosely linked
Realised vol 30D
37.3%
Annualised
Market vol 1Y
13.0%
SPY, annualised
Max drawdown 1Y
-18.2%
Peak to trough
Max drawdown 5Y
-68.9%
Peak to trough
ATR 14
2.21
3.27% of price
Beta (reported)
—
5Y monthly, from filing

PRIVATE STRATEGY · BY QUALIFICATION

The same data. A different seat.

The research you are reading is the input layer for a discretionary options program we run for a small number of qualified investors. Minimum $1,000,000.